People · Operator
Named in public records as an officer, director or promoter · active 2012–2023 · Biotech / Pharma, Other Technology, Biotechnology, AI / ML, Other, Computers
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pivot Bio, Inc. | — | Biotech / Pharma | Growth/Late | $622.6M | $13.0B | 2016 |
| Zymergen Inc. | — | Other Technology | Growth/Late | $580.2M | $13.2B | 2015 |
| Atomwise Inc. | — | Biotechnology | Series D+ | $238.6M | $124.3M | 2018 |
| Mythic Inc. | — | Other Technology | Series B | $102.8M | $250.0M | 2023 |
| Tradeshift Holdings Inc. | — | Other Technology | Series B | $86.2M | $614.3M | 2016 |
| Jupiter Intelligence, Inc. | — | AI / ML | Series C | $76.7M | $1.5B | 2019 |
| Vium, Inc. | — | Other | Series B | $35.4M | $38.8M | 2015 |
| 3Scan Inc. | — | Other Technology | Series A | $33.7M | $388.4M | 2016 |
| BlueTalon, Inc. | — | Other Technology | Series B | $25.9M | $486.6M | 2013 |
| Nervana Systems, Inc. | — | Computers | Series B | $24.4M | $748.0M | 2015 |
| Mosaic ML, Inc. | — | AI / ML | Series B | $21.7M | $580.5M | 2021 |
| Fortem Technologies, Inc. | — | Software / Tech | Series B | $16.4M | $498.6M | 2018 |
| u9t, Inc. | — | Other Technology | Pre-Seed | $1.0M | $16.9M | 2012 |
Matt Ocko at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matt Ocko on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ed Cluss | 2 | 4 |
| Shahin Farshchi | 2 | 4 |
| Naveen Rao | 2 | 2 |
| Peter Barrett | 1 | 18 |
| Andrew Perlman | 1 | 15 |
| Rohit Sharma | 1 | 10 |
| Nick Sturiale | 1 | 10 |
| Steve Jurvetson | 1 | 10 |
| Adam Goulburn | 1 | 10 |
| Scott Barclay | 1 | 8 |
| Andreas Stavropoulos | 1 | 8 |
| Annalisa Jenkins | 1 | 8 |
| John Hamer | 1 | 7 |
| Edward Shenderovich | 1 | 6 |
| Andrew Klein | 1 | 6 |
| Roger Wyse | 1 | 5 |
| Adam Seabrook | 1 | 5 |
| Robert Mittendorff | 1 | 5 |
| Andrew Preston | 1 | 5 |
| Armen Vidian | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.